FDA OKs Voluven for post-op blood loss

Dec 28, 2007

The U.S. Food and Drug Administration has approved Voluven as a treatment for blood loss after surgery.

Voluven is an intravenous solution that expands blood volume, the agency said Thursday in a release.

Significant blood loss can cause a rapid drop in the volume of red blood cells and plasma circulating through the body. This can lead to shock, which is potentially fatal.

Blood volume expanders are commonly administered to restore quickly some of the lost volume so remaining red blood cells can continue to deliver needed oxygen to the body's tissues, the FDA said.

Voluven, made by the German-firm Fresenius Kabi, contains a synthetic starch that does not dissolve in water. It was found in clinical trials to be as safe and effective as other blood volume expanders, the agency said.

The most common side effects from Voluven were nausea and itching.

Copyright 2007 by United Press International

Explore further: FDA warning: men's testosterone drugs overused (Update)

add to favorites email to friend print save as pdf

Related Stories

Living in the genetic comfort zone

1 hour ago

The information encoded in the DNA of an organism is not sufficient to determine the expression pattern of genes. This fact has been known even before the discovery of epigenetics, which refers to external ...

'Bright spot' on Ceres has dimmer companion

2 hours ago

Dwarf planet Ceres continues to puzzle scientists as NASA's Dawn spacecraft gets closer to being captured into orbit around the object. The latest images from Dawn, taken nearly 29,000 miles (46,000 kilometers) ...

Key facts on US 'open Internet' regulation

2 hours ago

A landmark ruling by the US Federal Communications Commission seeks to enshrine the notion of an "open Internet," or "net neutrality." Here are key points:

Spotify deals with random shuffle and we mortals

2 hours ago

How do we mortals perceive random sequences? An entry in the question-and-answer site Quora focused on a question involving a music-streaming service Spotify. That question signifies how we perceive what ...

Recommended for you

FDA warning: men's testosterone drugs overused (Update)

2 hours ago

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related ...

Early benefit assessment increases transparency for study data

6 hours ago

Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products (AMNOG). AMNOG was primarily aimed at containing the increasing drug expenditure of the statutory health insurance ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.